 | • レポートコード：MRC2304D090 • 出版社/出版日：Transparency Market Research / 2023年1月11日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートでは、マイクロRNAの世界市場を分析し、市場実態を明らかにしています。本書は、エグゼクティブサマリー、市場概要、市場背景、市場分析＆予測、サービス別（検体、サービス種類）分析、製品別（装置、消耗品）分析、用途別（がん、感染症、免疫疾患、循環器疾患、その他）分析、エンドユーザー別（バイオ＆製薬企業、学術＆政府研究機関、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争分析などを収録しています。また、Merck KGaA、Thermo Fisher Scientific, Inc.、Horizon Discovery Ltd.、Synlogic、QIAGEN、GeneCopoeia, Inc.、New England Biolabs、Quantabio、NanoString、BioGenex、SeqMatic LLC、Miltenyi Biotec、Sistemic Scotland Limited、Biodynamics Laboratory Inc.、OriGene Technologies, Inc.などの企業情報を掲載しています。 ・エグゼクティブサマリー ・市場概要 ・市場背景 ・市場分析＆予測 ・世界のマイクロRNA市場規模：サービス別 - 検体サービスの市場規模 - サービス種類の市場規模 ・世界のマイクロRNA市場規模：製品別 - 装置の市場規模 - 消耗品の市場規模 ・世界のマイクロRNA市場規模：用途別 - がんにおける市場規模 - 感染症における市場規模 - 免疫疾患における市場規模 - 循環器疾患における市場規模 - その他用途における市場規模 ・世界のマイクロRNA市場規模：エンドユーザー別 - バイオ＆製薬企業における市場規模 - 学術＆政府研究機関における市場規模 - その他エンドユーザーにおける市場規模 ・世界のマイクロRNA市場規模：地域別 - 北米のマイクロRNA市場規模 - 中南米のマイクロRNA市場規模 - ヨーロッパのマイクロRNA市場規模 - アジア太平洋のマイクロRNA市場規模 - 中東・アフリカのマイクロRNA市場規模 ・市場構造分析 ・競争分析 |
MicroRNA Market – Scope of Report
TMR’s report on the global microRNA market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global microRNA market for the period 2017–2031, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global microRNA market from 2023 to 2033.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the microRNA market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global microRNA market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global microRNA market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global microRNA market.
The report delves into the competitive landscape of the global microRNA market. Key players operating in the global microRNA market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global microRNA market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market microRNA.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. Value Chain Analysis
3.5.1. Profit Margin Analysis
3.5.2. Service Providers
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global microRNA Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Mn) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Services
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Services , 2018-2022
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Services , 2023-2033
5.3.1. Specimen
5.3.1.1. Whole Blood
5.3.1.2. Serum
5.3.1.3. Plasma
5.3.1.4. FFPE
5.3.1.5. Fresh Frozen Tissue
5.3.1.6. Other Specimens
5.3.2. Service Type
5.3.2.1. Isolation & Purification
5.3.2.2. miRNA cDNA Synthesis
5.3.2.3. Profiling, Localization, & Quantification
5.3.2.4. Functional Analysis
5.4. Y-o-Y Growth Trend Analysis By Services , 2018-2022
5.5. Absolute $ Opportunity Analysis By Services , 2023-2033
6. Global microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Products
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Products , 2018-2022
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Products , 2023-2033
6.3.1. Instruments
6.3.2. Consumables
6.4. Y-o-Y Growth Trend Analysis By Products , 2018-2022
6.5. Absolute $ Opportunity Analysis By Products , 2023-2033
7. Global microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2018-2022
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2023-2033
7.3.1. Cancer
7.3.2. Infectious Diseases
7.3.3. Immunological Disorder
7.3.4. Cardiovascular Disease
7.3.5. Neurological Disease
7.3.6. Other Applications
7.4. Y-o-Y Growth Trend Analysis By Application, 2018-2022
7.5. Absolute $ Opportunity Analysis By Application, 2023-2033
8. Global microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By End-use
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By End-use, 2018-2022
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-use, 2023-2033
8.3.1. Biotechnology & Pharmaceutical Companies
8.3.2. Academic & Government Research Institutes
8.3.3. Other End-user
8.4. Y-o-Y Growth Trend Analysis By End-use, 2018-2022
8.5. Absolute $ Opportunity Analysis By End-use, 2023-2033
9. Global microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2018-2022
9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. MEA
9.4. Market Attractiveness Analysis By Region
10. North America microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Services
10.2.3. By Products
10.2.4. By Application
10.2.5. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Services
10.3.3. By Products
10.3.4. By Application
10.3.5. By End-use
10.4. Key Takeaways
11. Latin America microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Services
11.2.3. By Products
11.2.4. By Application
11.2.5. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Services
11.3.3. By Products
11.3.4. By Application
11.3.5. By End-use
11.4. Key Takeaways
12. Europe microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. Italy
12.2.1.3. France
12.2.1.4. U.K.
12.2.1.5. Spain
12.2.1.6. Russia
12.2.1.7. Rest of Europe
12.2.2. By Services
12.2.3. By Products
12.2.4. By Application
12.2.5. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Services
12.3.3. By Products
12.3.4. By Application
12.3.5. By End-use
12.4. Key Takeaways
13. Asia Pacific microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. India
13.2.1.4. South Korea
13.2.1.5. Australia
13.2.1.6. Rest of APAC
13.2.2. By Services
13.2.3. By Products
13.2.4. By Application
13.2.5. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Services
13.3.3. By Products
13.3.4. By Application
13.3.5. By End-use
13.4. Key Takeaways
14. MEA microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
14.2.1. By Country
14.2.1.1. South Africa
14.2.1.2. Saudi Arabia
14.2.1.3. UAE
14.2.1.4. Israel
14.2.1.5. Rest of MEA
14.2.2. By Services
14.2.3. By Products
14.2.4. By Application
14.2.5. By End-use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Services
14.3.3. By Products
14.3.4. By Application
14.3.5. By End-use
14.4. Key Takeaways
15. Key Countries microRNA Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Services
15.1.2.2. By Products
15.1.2.3. By Application
15.1.2.4. By End-use
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Services
15.2.2.2. By Products
15.2.2.3. By Application
15.2.2.4. By End-use
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Services
15.3.2.2. By Products
15.3.2.3. By Application
15.3.2.4. By End-use
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Services
15.4.2.2. By Products
15.4.2.3. By Application
15.4.2.4. By End-use
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Services
15.5.2.2. By Products
15.5.2.3. By Application
15.5.2.4. By End-use
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Services
15.6.2.2. By Products
15.6.2.3. By Application
15.6.2.4. By End-use
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Services
15.7.2.2. By Products
15.7.2.3. By Application
15.7.2.4. By End-use
15.8. U.K.
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Services
15.8.2.2. By Products
15.8.2.3. By Application
15.8.2.4. By End-use
15.9. Spain
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Services
15.9.2.2. By Products
15.9.2.3. By Application
15.9.2.4. By End-use
15.10. Russia
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Services
15.10.2.2. By Products
15.10.2.3. By Application
15.10.2.4. By End-use
15.11. China
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Services
15.11.2.2. By Products
15.11.2.3. By Application
15.11.2.4. By End-use
15.12. Japan
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Services
15.12.2.2. By Products
15.12.2.3. By Application
15.12.2.4. By End-use
15.13. India
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Services
15.13.2.2. By Products
15.13.2.3. By Application
15.13.2.4. By End-use
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Services
15.14.2.2. By Products
15.14.2.3. By Application
15.14.2.4. By End-use
15.15. Australia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Services
15.15.2.2. By Products
15.15.2.3. By Application
15.15.2.4. By End-use
15.16. South Africa
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Services
15.16.2.2. By Products
15.16.2.3. By Application
15.16.2.4. By End-use
15.17. Saudi Arabia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Services
15.17.2.2. By Products
15.17.2.3. By Application
15.17.2.4. By End-use
15.18. UAE
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Services
15.18.2.2. By Products
15.18.2.3. By Application
15.18.2.4. By End-use
15.19. Israel
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Services
15.19.2.2. By Products
15.19.2.3. By Application
15.19.2.4. By End-use
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Services
16.3.3. By Products
16.3.4. By Application
16.3.5. By End-use
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Merck KGaA
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Thermo Fisher Scientific, Inc
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Horizon Discovery Ltd.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Synlogic
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. QIAGEN
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. GeneCopoeia Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. New England Biolabs
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Quantabio
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. NanoString
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. BioGenex
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. SeqMatic LLC
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Miltenyi Biotec
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodolog